1370TiP Befotertinib versus icotinib as first-line treatment in patients with advanced or metastatic EGFR-mutated non-small cell lung cancer: A multicenter, randomized, open-label, controlled phase III study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1971 ◽

2021 ◽

Vol 32 ◽

pp. S1038

Author(s):

S. Lu ◽

J. Zhou ◽

H. Jian ◽

L. Wu ◽

Y. Cheng ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

Egfr Mutated ◽

First Line Treatment

Download Full-text

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

Annals of Oncology ◽

10.1016/j.annonc.2020.10.479 ◽

2021 ◽

Vol 32 (1) ◽

pp. 85-96 ◽

Author(s):

M. Shi ◽

A. Gu ◽

H. Tu ◽

C. Huang ◽

H. Wang ◽

...

Keyword(s):

Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text

PD4-2-3: Global Lung Oncology Branch trial 3 (Glob 3): final results of a randomised multinational Phase III study of oral and i.v. vinorelbine (NVB) plus cisplatin (CDDP) versus docetaxel (DTX) plus CDDP as first-line treatment for advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283381.78585.f2 ◽

2007 ◽

Vol 2 (8) ◽

pp. S451

Author(s):

Eng-Huat Tan ◽

Tomasz Grodzki ◽

Claus-Peter Schneider ◽

Peter Zatloukal ◽

Martin Reck ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

Squire: a Randomized, Multicenter, Open-Label, Phase III Study of Gemcitabine-Cisplatin (Gc) Chemotherapy Plus Necitumumab (Imc-11F8/Ly3012211) Vs Gc Alone in the First-Line Treatment of Patients (Pts) with Stage Iv Squamous Non-Small Cell Lung Cancer (Sq-Nsclc): Update on Key Subgroups

Annals of Oncology ◽

10.1093/annonc/mdu349.11 ◽

2014 ◽

Vol 25 ◽

pp. iv430 ◽

Author(s):

M.A. Socinski ◽

L. Paz-Ares ◽

A.V. Luft ◽

A. Szczesna ◽

T.E. Ciuleanu ◽

...

Keyword(s):

Stage Iv ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Open Label Phase ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

FLEX: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.3 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 3-3 ◽

Author(s):

R. Pirker ◽

A. Szczesna ◽

J. von Pawel ◽

M. Krzakowski ◽

R. Ramlau ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Multicenter Phase ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin (GC) chemotherapy plus necitumumab (IMC-11F8/LY3012211) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8008 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8008-8008 ◽

Author(s):

Nick Thatcher ◽

Fred R. Hirsch ◽

Aleksandra Szczesna ◽

Tudor-Eliade Ciuleanu ◽

Wojciech Szafranski ◽

...

Keyword(s):

Stage Iv ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Open Label Phase ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdn774 ◽

2009 ◽

Vol 20 (7) ◽

pp. 1249-1256 ◽

Author(s):

E.H. Tan ◽

J. Rolski ◽

T. Grodzki ◽

C.P. Schneider ◽

U. Gatzemeier ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

O-51 Phase III study (TAX 326) of docetaxel-cisplatin (DC) and docetaxel-carboplatin (DCB) versus vinorelbine-cisplatin (VC) for the first-line treatment of advanced/metastatic non-small cell lung cancer (NSCLC): analyses in elderly patients

Lung Cancer ◽

10.1016/s0169-5002(03)91709-0 ◽

2003 ◽

Vol 41 ◽

pp. S18 ◽

Author(s):

Chandra P. Belani ◽

Frank V. Fossella

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

P-452 Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender

Lung Cancer ◽

10.1016/s0169-5002(05)80945-6 ◽

2005 ◽

Vol 49 ◽

pp. S235 ◽

Author(s):

C. Belani ◽

J. von Pawel ◽

A. Pluzanska ◽

V. Gorbounova ◽

E. Kaukel ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

Phase III study of gefitinib (G) versus gefitinib+carboplatin+pemetrexed (GCP) as first-line treatment for patients (pts) with advanced non-small cell lung cancer (NSCLC) with EGFR mutations (NEJ009)

Annals of Oncology ◽

10.1093/annonc/mdy292.005 ◽

2018 ◽

Vol 29 ◽

pp. viii496 ◽

Author(s):

M. Seike ◽

A. Inoue ◽

S. Sugawara ◽

S. Morita ◽

Y. Hosomi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Iii ◽

Egfr Mutations ◽

Line Treatment ◽

Small Cell Lung ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

B3-03: A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with Taxane/Carboplatin versus Taxane/Carboplatin alone as first-line treatment for patients with advanced/metastatic Non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283155.03863.e7 ◽

2007 ◽

Vol 2 (8) ◽

pp. S340-S341 ◽

Author(s):

Thomas J. Lynch ◽

Taral Patel ◽

Luke Dreisbach ◽

Michael McCleod ◽

William J. Heim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

Multicenter Phase ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text